PEPTALK: Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier Presentation
AACR 2019 Meeting: Altered myeloid & lymphoid composition of tumor microenvironment following anti-SEMA4D and immunotherapies
AACR 2019 Meeting: Integrated biomarker trials of VX15/2503 (pepinemab) in combination with checkpoint inhibitors in window of opportunity studies in solid tumors
AACR 2019 Meeting: Interim results from CLASSICAL-Lung, a phase 1b/2 Study of VX15/2503 (pepinemab) in combination with avelumab in advanced NSCLC